EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION

Objective: to assess the efficacy, safety and tolerability of the new combined medication Allergoferon® beta in patients with moderate-to-severe hay fever (seasonal allergic rhinitis and conjunctivitis) during periods of exacerbation. patients and methods: the object of our study was medication Alle...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A. A. Ryabtseva, N. Y. Sotnikova, O. V. Chumikov, N. A. Stupakova
Format: Artigo
Langue:Russo
Publié: Ophthalmology Publishing Group 2016-09-01
Collection:Oftalʹmologiâ
Sujets:
hay fever
efficacy
safety
recombinant interferon
betamethasone
allergoferon® beta
Accès en ligne:https://www.ophthalmojournal.com/opht/article/view/324
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires